Medreich Australia

Medreich Australia is a subsidiary of Medreich, a global pharmaceutical company headquartered in India and owned by the Japanese conglomerate Meiji Seika Pharma. The company operates as a leading Contract Development and Manufacturing Organization (CDMO) and a supplier of high-quality generic medicines. Its extensive product portfolio includes anti-infectives, cardiovascular treatments, and medications for central nervous system disorders. Medreich Australia is responsible for the commercialization, regulatory compliance, and distribution of these products across the Oceania region. The company utilizes its parent organization's world-class manufacturing facilities, which are accredited by major international regulatory agencies including the TGA and MHRA.